Bellerophon Therapeutics Inc earnings missed by $0.04, revenue was in line with estimates

  • Investing.com
Bellerophon Therapeutics Inc earnings missed by $0.04, revenue was in line with estimates

Investing.com - Bellerophon Therapeutics Inc (NASDAQ: BLPH) reported first quarter EPS of $-0.520, $0.04 worse than the analyst estimate of $-0.480. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.

Bellerophon Therapeutics Inc's stock price closed at $7.460. It is up 0% in the last 3 months and up 228.950% in the last 12 months.

Bellerophon Therapeutics Inc saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Bellerophon Therapeutics Inc's stock price’s past reactions to earnings here.

According to InvestingPro, Bellerophon Therapeutics Inc's Financial Health score is "fair performance".

Check out Bellerophon Therapeutics Inc's recent earnings performance , and Bellerophon Therapeutics Inc's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100